ABSTRACT
N-retinylidene-N-retinylethanolamine (A2E) plays a central role in age-related macular degeneration (AMD) by inducing angiogenesis and inflammation. A2E effects are mediated at least partly via the retinoic acid receptor (RAR)-α. Here we show that A2E binds and transactivates also peroxisome proliferator-activated receptors (PPAR) and retinoid X receptors (RXR). 9'-cis-norbixin, a di-apocarotenoid is also a ligand of these nuclear receptors (NR). Norbixin inhibits PPAR and RXR transactivation induced by A2E. Moreover, norbixin reduces protein kinase B (AKT) phosphorylation, NF-κB and AP-1 transactivation and mRNA expression of the inflammatory interleukins (IL) -6 and -8 and of vascular endothelial growth factor (VEGF) enhanced by A2E. By contrast, norbixin increases matrix metalloproteinase 9 (MMP9) and C-C motif chemokine ligand 2 (CCL2) mRNA expression in response to A2E. Selective PPAR-α, -ß/δ and -γ antagonists inhibit the expression of IL-6 and IL-8 while only the antagonist of PPAR-γ inhibits the transactivation of NF-κB following A2E exposure. In addition, a cocktail of all three PPARs antagonists and also HX531, an antagonist of RXR reproduce norbixin effects on inflammation. Altogether, A2E's deleterious biological effects could be inhibited through PPAR and RXR regulation. Moreover, the modulation of these NR by norbixin may open new avenues for the treatment of AMD.
Subject(s)
Carotenoids/administration & dosage , Macular Degeneration/drug therapy , PPAR alpha/immunology , PPAR delta/immunology , PPAR gamma/immunology , PPAR-beta/immunology , Retinal Pigment Epithelium/drug effects , Retinoids/immunology , Angiogenesis Inhibitors/administration & dosage , Animals , Humans , Macular Degeneration/chemically induced , Macular Degeneration/genetics , Macular Degeneration/immunology , Neovascularization, Pathologic/drug therapy , Neovascularization, Pathologic/etiology , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/immunology , PPAR alpha/genetics , PPAR delta/genetics , PPAR gamma/genetics , PPAR-beta/genetics , Retinal Pigment Epithelium/immunology , Retinoid X Receptors/agonists , Retinoid X Receptors/genetics , Retinoid X Receptors/immunology , Retinoids/adverse effects , Swine , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor A/immunologyABSTRACT
The skin is the largest epithelial surface protecting the body from invading microbes. Vitamin A plays vital roles in the host defence of the skin, including promoting epithelial cell integrity, proliferation, and differentiation and even mediating immune responses. Furthermore, vitamin A derivatives, retinoid drugs, are widely used to treat skin diseases, such as acne and psoriasis. However, the immunoregulatory mechanisms of retinoids in dermatology have not been systematically described. In this paper, we discuss the immunological functions of retinoids during disease treatment, especially in skin disorders caused by exogenous infections.
Subject(s)
Dermatology/trends , Epithelial Cells/physiology , Immunologic Factors/therapeutic use , Retinoids/immunology , Skin Diseases/immunology , Skin/drug effects , Vitamin A/therapeutic use , Animals , Humans , Immunity , Retinoids/therapeutic use , Skin/pathology , Skin Diseases/therapyABSTRACT
Acne has long been understood to have a complex physiological basis involving several main factors: hormonally-stimulated sebum production, abnormal keratinization of the pilosebaceous duct, and an inflammatory immune response to Propionibacterium acnes. Recent studies at the molecular and cellular level have begun clarifying how all of these factors interact, and the role of the innate immune system is better appreciated. Inflammation has been demonstrated in all acne lesions - the preclinical microcomedo, comedones, inflammatory lesions, 'post-inflammatory' erythema or hyperpigmentation, and scarring. Inflammation localized to the pilosebaceous unit can be considered the defining feature of acne and should be addressed via multiple therapeutic pathways. Clinicians tend to think oral antibiotics should be used to 'calm' inflammatory acne, but there is good evidence showing that topical retinoids also have anti-inflammatory properties as a class effect. For best therapeutic outcomes, most patients with acne should be treated first line with a topical retinoid plus an antimicrobial agent, as has been demonstrated in thousands of patients involved in clinical trials and recommended by the Global Alliance to Improve Outcomes in Acne for more than a decade. Moving away from reliance on antibiotic therapy for acne is particularly important in an era of worsening antimicrobial resistance and worldwide calls to reduce antibiotic use. Improved understanding about the role of P. acnes and the innate immune system in acne should help clinicians in designing efficacious treatment strategies.
Subject(s)
Acne Vulgaris/drug therapy , Acne Vulgaris/etiology , Gram-Positive Bacterial Infections/complications , Immunity, Innate , Propionibacterium acnes/immunology , Retinoids/immunology , Anti-Bacterial Agents/therapeutic use , Gram-Positive Bacterial Infections/immunology , Hair Follicle , Humans , Inflammasomes , Inflammation/immunology , Retinoids/therapeutic use , Toll-Like Receptors/metabolismABSTRACT
Previous work in our laboratory has shown that transglutaminase 2 (TG2) acting as a coreceptor for integrin ß3 is required for proper phagocytosis of apoptotic cells. In the absence of TG2, systemic lupus erythematosus-like autoimmunity develops in mice, similarly to other mice characterized by a deficiency in the clearance of apoptotic cells. In this study, we demonstrate that increasing TG2 expression alone in wild-type macrophages is not sufficient to enhance engulfment. However, during engulfment, the lipid content of the apoptotic cells triggers the lipid-sensing receptor liver X receptor (LXR), which in response upregulates the expression of the phagocytic receptor Mer tyrosine kinase and the phagocytosis-related ABCA1, and that of retinaldehyde dehydrogenases leading to the synthesis of a nonclassical retinoid. Based on our retinoid analysis, this compound might be a dihydro-retinoic acid derivative. The novel retinoid then contributes to the upregulation of further phagocytic receptors including TG2 by ligating retinoic acid receptors. Inhibition of retinoid synthesis prevents the enhanced phagocytic uptake induced by LXR ligation. Our data indicate that stimulation of LXR enhances the engulfment of apoptotic cells via regulating directly and indirectly the expression of a range of phagocytosis-related molecules, and its signaling pathway involves the synthesis of a nonclassical retinoid. We propose that retinoids could be used for enhancing the phagocytic capacity of macrophages in diseases such as systemic lupus erythematosus, where impaired phagocytosis of apoptotic cells plays a role in the pathogenesis of the disease.
Subject(s)
Apoptosis/immunology , Macrophages, Peritoneal/immunology , Phagocytosis/immunology , Retinoids/immunology , ATP Binding Cassette Transporter 1/genetics , ATP Binding Cassette Transporter 1/immunology , Animals , Apoptosis/genetics , GTP-Binding Proteins/genetics , GTP-Binding Proteins/immunology , Liver X Receptors , Lupus Erythematosus, Systemic/genetics , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/pathology , Macrophages, Peritoneal/pathology , Mice , Mice, Knockout , Orphan Nuclear Receptors/genetics , Orphan Nuclear Receptors/immunology , Phagocytosis/genetics , Protein Glutamine gamma Glutamyltransferase 2 , Retinoids/genetics , Transglutaminases/genetics , Transglutaminases/immunologyABSTRACT
There are more than 4000 natural and synthetic molecules structurally and/or functionally related to vitamin A. Retinoids are a class of these compounds that are structurally associated to vitamin A. The retinoids have a wide spectrum of functions. Retinoic acid, which is the active metabolite of retinol, regulates a wide range of biological processes including development, differentiation, proliferation and apoptosis. It suppresses carcinogenesis in tumorigenic animal models for the skin, oral, lung, breast, bladder, ovarian and prostate. It is important how major retinoids may act in cancer treatment or prevention. The reports have indicated that lower levels of vitamin A in humans may be associated with relative type 1 cytokine dominance and a higher proportion of NK cells. In addition, very low vitamin A levels would be undesirable explaining the essential role of vitamin A in epithelial and general cell maturation and function. However, the cytokine shifts associated with moderately low levels of vitamin A may be in some ways beneficial in an environment where HIV infection, M. tuberculosis infection, or other type 1 infections are highly prevalent and/or when acquired immunity is cooperated. In this review, we intend to describe the biochemical and immunological functions of retinoids against cancer.
Subject(s)
Epithelium/metabolism , Neoplasms/immunology , Retinoids/immunology , Adaptive Immunity , Animals , Disease Models, Animal , Humans , Immunity, Innate , Immunomodulation , Th1-Th2 BalanceABSTRACT
Alopecia areata (AA) is an autoimmune disease that attacks anagen hair follicles. Gene array in graft-induced C3H/HeJ mice revealed that genes involved in retinoic acid (RA) synthesis were increased, whereas RA degradation genes were decreased in AA compared with sham controls. This was confirmed by immunohistochemistry in biopsies from patients with AA and both mouse and rat AA models. RA levels were also increased in C3H/HeJ mice with AA. C3H/HeJ mice were fed a purified diet containing one of the four levels of dietary vitamin A or an unpurified diet 2 weeks before grafting and disease progression followed. High vitamin A accelerated AA, whereas mice that were not fed vitamin A had more severe disease by the end of the study. More hair follicles were in anagen in mice fed high vitamin A. Both the number and localization of granzyme B-positive cells were altered by vitamin A. IFNγ was also the lowest and IL13 highest in mice fed high vitamin A. Other cytokines were reduced and chemokines increased as the disease progressed, but no additional effects of vitamin A were seen. Combined, these results suggest that vitamin A regulates both the hair cycle and immune response to alter the progression of AA.
Subject(s)
Alopecia Areata/etiology , Alopecia Areata/pathology , Hair Follicle/pathology , Retinoids/metabolism , Alopecia Areata/immunology , Animal Feed , Animals , Biopsy , Chemokine CCL5/metabolism , Chemokine CXCL9/metabolism , Disease Progression , Granzymes/metabolism , Hair Follicle/growth & development , Hair Follicle/metabolism , Humans , Interferon-gamma/metabolism , Interleukin-13/metabolism , Mice , Mice, Inbred C3H , Rats , Retinoids/biosynthesis , Retinoids/immunology , Tissue Banks , Vitamin A/pharmacologyABSTRACT
Transforming growth factor-ß (TGF-ß) isoforms are profibrotic cytokines, par excellence, and have complex multifunctional effects on many systems, depending on the biologic setting. Retinoids are vitamin A derivatives that also have diverse effects in development, physiology, and disease. The interactions between these classes of molecules are, not surprisingly, highly complex and are dependent on the tissue, cellular, and molecular settings.
Subject(s)
Neoplasms/metabolism , Retinoids/metabolism , Transforming Growth Factor beta/metabolism , Wound Healing/physiology , Embryonic Development/physiology , Fetal Development/physiology , Humans , Neoplasms/drug therapy , Receptors, Retinoic Acid/immunology , Receptors, Retinoic Acid/metabolism , Retinoid X Receptors/immunology , Retinoid X Receptors/metabolism , Retinoids/immunology , Retinoids/therapeutic use , Signal Transduction , Transforming Growth Factor beta/immunology , Tretinoin/immunology , Tretinoin/metabolism , Vitamin A/immunology , Vitamin A/metabolismABSTRACT
Small intestinal lamina propria (SI-LP) CD103(+) dendritic cells (DCs) are imprinted with an ability to metabolize vitamin A (retinol), a property underlying their enhanced capacity to induce the gut-homing receptors CC chemokine receptor-9 and α4ß7 on responding T cells. In this study, we demonstrate that imprinting of CD103(+) DCs is itself critically dependent on vitamin A and occurs locally within the small intestine (SI). The major vitamin A metabolite retinoic acid (RA) induced retinol-metabolizing activity in DCs both in vitro and in vivo, suggesting a direct role for RA in this process. Consistent with this, SI-LP CD103(+) DCs constitutively received RA signals in vivo at significantly higher levels than did colonic CD103(+) DCs. Remarkably, SI CD103(+) DCs remained imprinted in mice depleted of dietary but not of systemic retinol. We found that bile contained high levels of retinol, induced RA receptor-dependent retinol-metabolizing activity in bone marrow-derived DCs, and imprinted these cells with the ability to generate gut-tropic T cells. Taken together, these results suggest a novel and unexpected role for bile in SI-LP CD103(+) DC imprinting.
Subject(s)
Bile/metabolism , Dendritic Cells/immunology , Dendritic Cells/metabolism , Intestinal Mucosa/metabolism , Intestines/immunology , Retinoids/metabolism , T-Lymphocytes/immunology , Animals , Antigens, CD/immunology , Antigens, CD/metabolism , Bile/chemistry , Bile/immunology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cells, Cultured , Dendritic Cells/cytology , Diet , Integrin alpha Chains/immunology , Integrin alpha Chains/metabolism , Lymph Nodes/immunology , Lymph Nodes/metabolism , Mice , Mice, Inbred C57BL , Receptors, CCR/metabolism , Retinoids/immunology , Signal Transduction/immunology , T-Lymphocytes/cytology , Vitamin A/analysisABSTRACT
Retinoids are known to promote T helper (Th)2 and regulatory T cell (Treg) differentiation, and suppress Th1 and Th17 in vitro. Am80, a synthetic retinoid, is reported to ameliorate collagen-induced arthritis (CIA). The aims of this study are to determine the effects of Am80 on CIA in detail, and on Th development and antibody (Ab) production in vivo. Murine CIA was induced by immunization with bovine type II collagen (CII) at days 1 and 22. Treatment with Am80 from day 1 to 35 significantly lowered clinical arthritis score, suppressed cellular infiltration and bone destruction in the joint, decreased interleukin (IL)-17 and increased interferon (IFN)-gamma production by CII-stimulated splenocytes, and decreased proportion of Foxp3(+) splenic CD4 T cells and serum anti-CII Ab levels. Thus, Am80 inhibited Th17 and Treg and enhanced Th1 differentiation in vivo. In contrast, Am80 applied from day 15 to 35 did not alter arthritis score, IL-17 or IFN-gamma production by CII-stimulated splenocytes, but decreased the proportion of Foxp3(+) splenic CD4 T cells and serum anti-CII Ab levels. Am80 exhibits inhibitory effects on CIA and might regulate both Th development and Ab production in vivo. Decreased Th17 by treatment with Am80 might be responsible for the attenuation of arthritis.
Subject(s)
Antibody Formation/drug effects , Arthritis, Experimental/immunology , Benzoates/pharmacology , T-Lymphocytes, Helper-Inducer/drug effects , Tetrahydronaphthalenes/pharmacology , Animals , Antibody Formation/immunology , Arthritis, Experimental/drug therapy , Benzoates/immunology , Benzoates/therapeutic use , Cell Differentiation/drug effects , Cell Differentiation/immunology , Enzyme-Linked Immunosorbent Assay , Joints/drug effects , Joints/immunology , Male , Mice , Mice, Inbred DBA , Retinoids/immunology , Retinoids/pharmacology , Retinoids/therapeutic use , Severity of Illness Index , T-Lymphocytes, Helper-Inducer/immunology , Tetrahydronaphthalenes/immunology , Tetrahydronaphthalenes/therapeutic useABSTRACT
We have demonstrated that cytokine thymic stromal lymphopoietin (TSLP), whose expression is rapidly induced upon keratinocyte-selective ablation of retinoid X receptors (RXRs) -alpha and -beta in the mouse (RXRalphabeta(ep-/-) mice), plays a key role in initiating a skin and systemic atopic dermatitis-like phenotype. We show here that topical application of the physiologically active ligand [1alpha,25-(OH)(2)D(3); calcitriol] of the vitamin D receptor, or of its low-calcemic analog MC903 (calcipotriol; Dovonex), induces TSLP expression in epidermal keratinocytes, which results in an atopic dermatitis-like syndrome mimicking that seen in RXRalphabeta(ep-/-) mutants and transgenic mice overexpressing TSLP in keratinocytes. Furthermore, topical application of retinoic acid receptor RARgamma-selective agonist BMS961 also induces TSLP expression either on its own or synergistically with 1alpha,25-(OH)(2)D(3). Our data demonstrate that RXR/vitamin D receptor and RXR/retinoic acid receptor-gamma heterodimers and their ligands cell-autonomously control the expression of TSLP in epidermal keratinocytes of the mouse. We propose molecular mechanisms through which vitamin D3 and retinoic acid signalings could be involved in the pathogenesis of atopic diseases.
Subject(s)
Calcitriol/analogs & derivatives , Cytokines/immunology , Dermatitis, Atopic , Dermatologic Agents , Keratinocytes/immunology , Vitamins , Administration, Topical , Animals , Calcitriol/administration & dosage , Calcitriol/adverse effects , Calcitriol/immunology , Calcium/metabolism , Cells, Cultured , Cytokines/genetics , Dermatitis, Atopic/chemically induced , Dermatitis, Atopic/immunology , Dermatologic Agents/administration & dosage , Dermatologic Agents/adverse effects , Dermatologic Agents/immunology , Dimerization , Female , Humans , Keratinocytes/cytology , Mice , Mice, Knockout , Mice, Transgenic , Receptors, Calcitriol/genetics , Receptors, Calcitriol/metabolism , Receptors, Retinoic Acid/agonists , Receptors, Retinoic Acid/genetics , Receptors, Retinoic Acid/metabolism , Retinoid X Receptor alpha/agonists , Retinoid X Receptor alpha/genetics , Retinoid X Receptor alpha/metabolism , Retinoid X Receptor beta/agonists , Retinoid X Receptor beta/genetics , Retinoid X Receptor beta/metabolism , Retinoids/immunology , Skin/cytology , Skin/drug effects , Skin/pathology , Vitamins/administration & dosage , Vitamins/adverse effects , Vitamins/chemistry , Vitamins/immunology , Thymic Stromal Lymphopoietin , Retinoic Acid Receptor gammaABSTRACT
New research has refined our understanding of the immunopathophysiology of acne. Various immune factors, including both innate and adaptive immune responses, have been implicated in the pathophysiology of inflammatory acne. Topical retinoids such as tretinoin, adapalene, and tazarotene, exhibit immunomodulatory effects that may help to explain their efficacy in the resolution of inflammatory lesions.
Subject(s)
Acne Vulgaris/immunology , Dermatologic Agents/immunology , Inflammation/immunology , Propionibacterium acnes/immunology , Retinoids/immunology , Acne Vulgaris/drug therapy , Administration, Topical , Animals , Dermatologic Agents/therapeutic use , Guinea Pigs , Humans , Inflammation/physiopathology , Propionibacterium acnes/drug effects , Retinoids/therapeutic use , Toll-Like Receptors/immunologyABSTRACT
Newly hatched Japanese quail (Coturnix coturnix japonica) chicks were fed diets containing different levels of retinoids (vitamin A) or beta-carotene. Group A received a commercial diet containing 10,000 IU vitamin A per kilogram. The diets of Groups B, C, and D contained no vitamin A but were supplemented with 1-, 2.5-, and 5-fold retinol equivalents of beta-carotene. Each group contained 16 quails in a 1:1 sex ratio. At 8 weeks of age the quails were immunized orally with Newcastle disease virus (NDV) vaccine according to the manufacturer's recommendations. Boosters were given three times at two-week intervals. Blood samples were taken at two-week intervals until 14 weeks of age. The anti-NDV IgY titre was determined by a locally developed direct enzyme-linked immunosorbent assay (ELISA). Groups A and B showed nearly the same antibody response. This indicates that the preformed vitamin A and the equivalent beta-carotene have the same immunomodulatory effect. Groups receiving higher doses of beta-carotene (Groups C and D) exhibited significantly higher plasma IgY levels compared to Groups A and B. The results indicate that elevated doses of beta-carotene have a slight effect on the adaptive immune response in Japanese quail.
Subject(s)
Coturnix/immunology , Dietary Supplements , Egg Yolk/immunology , Immunoglobulins/metabolism , Newcastle Disease/prevention & control , Viral Vaccines/immunology , beta Carotene/pharmacology , Animals , Coturnix/blood , Egg Yolk/drug effects , Enzyme-Linked Immunosorbent Assay , Female , Immunoglobulins/drug effects , Immunoglobulins/immunology , Male , Retinoids/administration & dosage , Retinoids/blood , Retinoids/immunology , Time Factors , Viral Vaccines/blood , beta Carotene/administration & dosage , beta Carotene/blood , beta Carotene/immunologyABSTRACT
The retinoids are compounds structurally related to vitamin A. The most extensively studied agents in cancer medicine include all-trans-retinoic acid, 9-cis-retinoic acid, and 13-cis-retinoic acid. In addition to several described immune regulatory functions, these agents may exert their antineoplastic effects through the regulation of tumor suppressor genes such as RAR-beta2. The survival benefit provided to patients with acute promyelocytic leukemia (APL) after induction therapy with all-trans RA and the responses experienced by patients with cutaneous lesions from Kaposi's sarcoma and cutaneous T cell lymphoma treated with 9-cis RA and a selective rexinoid--bexarotene--respectively, led to their approval by the Food and Drug Administration during the last decade. As chemopreventive agents, retinoids have proven to effectively regress laryngeal papillomatosis and oral leukoplakia lesions. The ability of 13-cis-RA to prevent second primary malignancies in patients with carcinoma of the head and neck has also been demonstrated. Unfortunately, this intervention did not affect the primary tumor recurrence rates. The toxicity and efficacy of retinoids administered in combination with other biological and cytotoxic agents have also been explored in patients with renal cell carcinoma, breast cancer, myelodysplasia, prostate, cervix, and other malignancies with a broad range of reported responses. Further characterization of the molecular processes modulated by these agents will serve to better define their role in the prevention and treatment of human cancer and to tailor specific targeted therapies in combination with other compounds. Newer and more selective retinoids and rexinoids are completing phase I and phase II studies and hold promising.
Subject(s)
Neoplasms/drug therapy , Retinoids/therapeutic use , Clinical Trials as Topic , Drug Resistance, Neoplasm , Humans , Receptors, Retinoic Acid/metabolism , Retinoids/adverse effects , Retinoids/immunologyABSTRACT
Patients infected with the human immunodeficiency virus exhibit a progressive decline in the CD4 T-cell number, resulting in immunodeficiency and increased susceptibility to opportunistic infections and malignancies. Although CD4 T cell production is impaired in patients infected with HIV, there is now increasing evidence that the primary basis of T cell depletion is accelerated apoptosis of CD4 and CD8 T cells. The rate of lymphocyte apoptosis in HIV infection correlates inversely with the progression of the disease: it is low in long-term progressors and in patients undergoing highly active antiretroviral therapy. Interestingly, only a minor fraction of apoptotic lymphocytes are infected by HIV, indicating that the enhanced apoptosis does not necessarily always serve to remove the HIV+ cells and results from mechanisms other than direct infection. Thus, understanding and influencing the mechanisms of HIV-associated lymphocyte apoptosis may lead to new therapies for HIV disease. In this paper the potential effects of retinoids on CD4 T cell apoptosis is discussed.
Subject(s)
Apoptosis , CD4-Positive T-Lymphocytes/physiology , CD8-Positive T-Lymphocytes/physiology , HIV Infections/etiology , Retinoids/immunology , Retinoids/physiology , HIV/genetics , Humans , Lymphocyte Activation , Viral ProteinsABSTRACT
Retinoids, natural and synthetic analogues of vitamin A, have demonstrated promising results in pre-clinical and clinical trials of cancer prevention and therapy. This chapter reviews the ability of retinoids to suppress tumor growth and metastasis in vivo and to inhibit invasion in vitro. The mechanisms of these effects include suppression of growth and enhancement of differentiation of malignant cells, inhibition of their ability to produce degradative enzymes required for invasion, suppression of migration, inhibition of neovascularization, and augmentation of host anti-tumor immune responses.
Subject(s)
Neoplasm Invasiveness , Neoplasm Metastasis , Retinoids/pharmacokinetics , Animals , Cell Adhesion/drug effects , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Movement/drug effects , Extracellular Matrix Proteins/drug effects , Glycosylation/drug effects , Humans , Immunity, Cellular/drug effects , Mice , Rats , Retinoids/immunologyABSTRACT
It has been estimated that 35% of all cancer incidence is related to diet. The potential appears great that high intakes of various nutrients can reduce the incidence of some types of cancer. Selenium and vitamins A, C, and E, discussed in this article, have many actions and interactions that are important in relationship to the study of nutrition and cancer. Even though only a few of the necessary human trials of efficacy have been conducted, epidemiological and animal data suggest that vitamins and/or minerals act as anticarcinogens, altering cancer incidence, differentiation, and growth. Thus, they may prove useful adjuncts to conventional therapies or in cancer prevention. However, the nutrients should not be viewed as cure-alls that work alone. Adequate intake ideally should be the result of increased dietary consumption rather than supplements because as yet unidentified components found in food may prove beneficial and protective. More research is needed prior to encouraging members of the general population to increase their intakes of various nutrients, even though there is now some evidence that those nutrients may help prevent some cancers.